Inflammation marker related to obesity is elevated in patients with pancreatic cancer

The levels of an inflammatory chemokine were significantly elevated in patients with pancreatic cancer who were extremely obese, according to research conducted by scientists at the Jefferson Pancreatic, Biliary and Related Cancers Centre. They presented their data at the 5th Annual Academic Surgical Congress, held in San Antonio...

Read the whole article on

More from